Annual Shareholders Equity
$617.76 M
+$255.26 M+70.42%
31 March 2024
Summary:
Immunovant annual stockholders equity is currently $617.76 million, with the most recent change of +$255.26 million (+70.42%) on 31 March 2024. During the last 3 years, it has risen by +$226.28 million (+57.80%). IMVT annual shareholders equity is now at all-time high.IMVT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$449.05 M
-$95.61 M-17.55%
30 September 2024
Summary:
Immunovant quarterly stockholders equity is currently $449.05 million, with the most recent change of -$95.61 million (-17.55%) on 30 September 2024. Over the past year, it has increased by +$197.24 million (+78.33%). IMVT quarterly shareholders equity is now -33.90% below its all-time high of $679.34 million, reached on 31 December 2023.IMVT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.4% | +78.3% |
| 3 y3 years | +57.8% | -16.3% |
| 5 y5 years | +10000.0% | +295.9% |
IMVT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.4% | -33.9% | +78.3% |
| 5 y | 5 years | at high | >+9999.0% | -33.9% | +377.4% |
| alltime | all time | at high | >+9999.0% | -33.9% | >+9999.0% |
Immunovant Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $449.05 M(-17.6%) |
| June 2024 | - | $544.66 M(-11.8%) |
| Mar 2024 | $617.76 M(+70.4%) | $617.76 M(-9.1%) |
| Dec 2023 | - | $679.34 M(+169.8%) |
| Sept 2023 | - | $251.81 M(-16.0%) |
| June 2023 | - | $299.87 M(-17.3%) |
| Mar 2023 | $362.49 M(-22.8%) | $362.49 M(-12.6%) |
| Dec 2022 | - | $414.68 M(+4.8%) |
| Sept 2022 | - | $395.75 M(-9.3%) |
| June 2022 | - | $436.49 M(-7.1%) |
| Mar 2022 | $469.82 M | $469.82 M(-7.0%) |
| Dec 2021 | - | $505.15 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $536.40 M(+46.7%) |
| June 2021 | - | $365.53 M(-6.6%) |
| Mar 2021 | $391.48 M(+316.2%) | $391.48 M(-5.5%) |
| Dec 2020 | - | $414.15 M(-5.5%) |
| Sept 2020 | - | $438.41 M(+63.7%) |
| June 2020 | - | $267.77 M(+184.7%) |
| Mar 2020 | $94.07 M(>+9900.0%) | $94.07 M(-15.9%) |
| Dec 2019 | - | $111.86 M(-1.4%) |
| Sept 2019 | - | $113.42 M(+0.1%) |
| June 2019 | - | $113.30 M(>+9900.0%) |
| Mar 2019 | - | $24.10 K |
| Dec 2018 | $24.60 K | - |
FAQ
- What is Immunovant annual stockholders equity?
- What is the all time high annual shareholders equity for Immunovant?
- What is Immunovant annual shareholders equity year-on-year change?
- What is Immunovant quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Immunovant?
- What is Immunovant quarterly shareholders equity year-on-year change?
What is Immunovant annual stockholders equity?
The current annual shareholders equity of IMVT is $617.76 M
What is the all time high annual shareholders equity for Immunovant?
Immunovant all-time high annual stockholders equity is $617.76 M
What is Immunovant annual shareholders equity year-on-year change?
Over the past year, IMVT annual stockholders equity has changed by +$255.26 M (+70.42%)
What is Immunovant quarterly stockholders equity?
The current quarterly shareholders equity of IMVT is $449.05 M
What is the all time high quarterly shareholders equity for Immunovant?
Immunovant all-time high quarterly stockholders equity is $679.34 M
What is Immunovant quarterly shareholders equity year-on-year change?
Over the past year, IMVT quarterly stockholders equity has changed by +$197.24 M (+78.33%)